A 股证券代码：600610 A 股证券简称：中毅达 公告编号：2024-071 B 股证券代码：900906 B 股证券简称：中毅达 B 贵州中毅达股份有限公司 关于全资子公司向关联方申请授信额度暨关联交易 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 一、关联交易概述 （一）赤峰瑞阳在南洋商业银行现有授信额度 7,000 万元，授信有效期至 2024 年 11 月 6 日，公司已提供信用担保。 贵州中毅达股份有限公司（以下简称"公司"）全资子公司赤峰瑞阳化工有限 公司（以下简称"赤峰瑞阳"）在南洋商业银行（中国）有限公司（以下简称"南 洋商业银行"）现有授信额度 7,000 万元即将到期，现赤峰瑞阳根据自身经营 发展需要及资金需求，拟继续向南洋商业银行申请 7,000 万元授信额度，授信 期限为 1 年，公司已提供信用担保。 本次交易构成关联交易。 本次交易未构成重大资产重组。 本次关联交易已经公司第九届董事会第四次会议审议通过，根据《上海证券 交易所股票上市规则》（以下简称《上市规则》）的 ...

上海证券交易所： 摩根士丹利证券（中国）有限公司（以下简称"摩根士丹利证券"或"本保 荐机构"，曾用名"摩根士丹利华鑫证券有限责任公司"）作为贵州中毅达股份 有限公司（以下简称"公司""上市公司"或"中毅达"，曾用名"上海中毅达 股份有限公司""中国纺织机械股份有限公司"）股权分置改革的保荐机构，根 据《中华人民共和国公司法》《中华人民共和国证券法》《关于上市公司股权分 置改革的指导意见》《上市公司股权分置改革管理办法》等相关法律、法规及规 范性文件，并结合公司原限售股份持有人在股权分置改革方案中作出的承诺情 况，公司部分因股权分置改革形成的限售股份自2024年9月23日起可上市流通。 本保荐机构对中毅达本次限售股份上市流通事项进行了核查，核查情况如下： 一、股权分置改革方案及实施情况概述 （一）股权分置改革方案简介 公司股权分置改革的方案采取"资产赠与对价+资本公积金转增股本+送股" 的组合方式进行股改对价安排，具体对价安排为： 1、资产赠与 摩根士丹利证券（中国）有限公司 关于贵州中毅达股份有限公司股权分置改革有限售条件的流通股 上市流通申请的核查意见 大申集团有限公司（以下简称"大申集团"）将向公司无偿 ...

证券代码：600610 证券简称：中毅达 公告编号：2024-068 900906 |中毅达 B 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 贵州中毅达股份有限公司 本次股票上市类型为股改后限售股份；股票认购方式为网下， 上市股数为 260,000,000 股。 股改限售股上市流通公告 本次股票上市流通总数为 260,000,000 股。 本次股票上市流通日期为 2024 年 9 月 23 日。 一、股权分置改革方案的相关情况 （一）贵州中毅达股份有限公司（原上海中毅达股份有限公司、中国纺织机 械股份有限公司，以下简称"公司"）股权分置改革于 2014 年 7 月 3 日经 2014 年 第一次临时股东大会暨股权分置改革相关股东会议审议通过，以 2014 年 11 月 21 日作为股权登记日实施，公司 A 股股票于 2014 年 11 月 25 日实施后首次复牌。 （二）公司股权分置改革方案是否安排追加对价：是 公司原控股股东大申集团有限公司（以下简称"大申集团"）承诺，公司 2014 年度实现的净利润 ...

| A | 股证券代码：600610 | A | 股证券简称：中毅达 公告编号：2024-067 | | --- | --- | --- | --- | | B | 股证券代码：900906 | B | 股证券简称：中毅达 B | 贵州中毅达股份有限公司 关于召开 2024 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2024 年 9 月 18 日（星期三）至 9 月 24 日（星期二）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 zhongyidash@163.com 进行提问。公司将在说明会上对投资者普遍关注的问 题进行回答。 贵州中毅达股份有限公司（以下简称"公司"）已于 2024 年 8 月 24 日发布 公司 2024 年半年度报告，为便于广大投资者更全面深入地了解公司 2024 年半年 度经营成果、财务状况，公司计划于 2024 年 ...

| B | A | | --- | --- | | 股证券代码：900906 | 股证券代码：600610 | | B | A | | 股证券简称：中毅达 B | 股证券简称：中毅达 | | | 公告编号：2024-065 | 贵州中毅达股份有限公司 2024 年半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 贵州中毅达股份有限公司（以下简称"公司"）根据上海证券交易所《上海 证券交易所上市公司自律监管指引第 3 号行业信息披露：第十三号——化工》的 相关要求，现将 2024 年半年度主要经营数据披露如下： 二、主要产品和原材料的价格变动情况 （一）主要产品价格变动情况 | 主要产品 | | 年 2024 | 1-6 | 月平均 | 2023 | 年 1-6 | 月平均 | 变动比例（%） | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 售价（元/吨） | | | | | 售价（元/吨） | | | | 季戊四醇 | 10,23 ...

Financial Performance - Revenue for the first half of 2024 was 565,343,854.89 RMB, a decrease of 3.75% compared to the same period last year[12] - Net profit attributable to shareholders of the listed company was -15,730,077.51 RMB, showing an improvement from the previous year's -31,369,460.12 RMB[12] - Net cash flow from operating activities increased by 31.40% to 39,659,887.90 RMB compared to the same period last year[12] - Basic earnings per share (EPS) for the reporting period (January to June) was -0.0147 yuan per share, compared to -0.0293 yuan per share in the same period last year[14] - Diluted EPS for the reporting period was -0.0147 yuan per share, unchanged from the same period last year[14] - Weighted average return on equity (ROE) for the reporting period was -100.11%, a decrease of 75.46 percentage points compared to the same period last year[14] - The company achieved a reduction in losses compared to the same period last year, driven by a slight recovery in sales prices of polyol products and a decrease in raw material procurement costs[14] - The company achieved revenue of 565 million yuan in the first half of 2024, a decrease of 3.75% year-on-year, with a net loss of 15.73 million yuan, reducing the loss by 15.64 million yuan compared to the same period last year[28] - Sales revenue of polyol series products increased by 9.74% year-on-year, while sales revenue of edible alcohol and DDGS feed decreased by 21.11% year-on-year[36] - Main business revenue was 560 million yuan, a year-on-year decrease of 3.77%[36] - R&D expenses increased by 32.16% year-on-year, reaching 6.05 million yuan[37] - Net cash flow from operating activities increased by 31.40% year-on-year, reaching 30.18 million yuan[37] - Operating revenue for the first half of 2024 was 565,343,854.89 RMB, a decrease from 587,392,629.79 RMB in the same period of 2023[104] - Operating costs for the first half of 2024 were 578,821,757.32 RMB, down from 619,095,316.57 RMB in the same period of 2023[104] - Net profit attributable to shareholders was -236,878,550.61 RMB as of June 30, 2024, compared to -223,172,308.31 RMB at the end of 2023[103] - Cash and cash equivalents increased to 18,342,760.23 RMB as of June 30, 2024, up from 10,582,750.37 RMB at the end of 2023[101] - Sales expenses decreased to 7,227,480.62 RMB in the first half of 2024, down from 8,939,142.88 RMB in the same period of 2023[104] - R&D expenses increased to 7,998,926.58 RMB, up from 6,052,670.97 RMB in the previous period[105] - Financial expenses rose to 21,027,510.49 RMB, compared to 19,380,647.08 RMB in the previous period[105] - Interest expenses increased to 22,686,252.00 RMB, up from 21,165,148.77 RMB[105] - Net profit loss deepened to -15,730,077.51 RMB, compared to -31,369,460.12 RMB in the previous period[105] - Basic earnings per share (EPS) stood at -0.0147 RMB, compared to -0.0293 RMB in the previous period[106] - Comprehensive income totaled -15,730,077.51 RMB, compared to -31,369,460.12 RMB in the previous period[106] - Management expenses decreased to 3,804,007.79 RMB, down from 5,629,806.18 RMB[107] - Interest income dropped to 36,911.13 RMB, compared to 19,594.11 RMB in the previous period[107] - Operating loss widened to -27,122,747.43 RMB, compared to -26,238,622.11 RMB in the previous period[109] - Net loss for the period was -27,139,964.85 RMB, compared to -26,323,465.73 RMB in the previous period[109] - Operating cash flow increased to 39.66 million yuan in the first half of 2024, up from 30.18 million yuan in the same period last year[110] - Net cash flow from financing activities was -17.20 million yuan in the first half of 2024, compared to -48.50 million yuan in the same period last year[111] - Cash and cash equivalents at the end of the period stood at 67.12 million yuan, up from 47.05 million yuan in the same period last year[111] - Net cash flow from investing activities was -1.10 million yuan in the first half of 2024, compared to -1.31 million yuan in the same period last year[111] - Cash received from sales of goods and services was 524.20 million yuan in the first half of 2024, down from 552.37 million yuan in the same period last year[110] - Cash paid for goods and services was 435.55 million yuan in the first half of 2024, down from 450.38 million yuan in the same period last year[110] - Cash received from financing activities was 74.15 million yuan in the first half of 2024, up from 71.69 million yuan in the same period last year[111] - Cash paid for employee benefits was 52.21 million yuan in the first half of 2024, down from 62.09 million yuan in the same period last year[110] - Cash received from tax refunds was 6.24 million yuan in the first half of 2024, down from 13.78 million yuan in the same period last year[110] - Cash paid for taxes was 3.59 million yuan in the first half of 2024, down from 3.95 million yuan in the same period last year[110] - Total comprehensive income for the period decreased by RMB 15.73 million[114] - Special reserve increased by RMB 420,768.61 during the period[115] - Total comprehensive income for the period decreased by RMB 31.37 million[117] - Special reserve increased by RMB 612,787.21 during the period[118] - Special reserve increased by RMB 1.99 million during the period[119] - Special reserve used amounted to RMB 1.38 million during the period[119] - The company's total comprehensive income for the first half of 2024 was a loss of RMB 27,139,964.85[120] - The company's undistributed profit decreased by RMB 13,706,242.30 in the first half of 2024[120] - The company's total owner's equity at the end of the first half of 2024 was RMB 896,022,489.82[121] - The company's capital reserve increased by RMB 13,433,722.55 in the first half of 2024[121] - The company's total comprehensive income for the first half of 2023 was a loss of RMB 26,323,465.73[122] - The company's total owner's equity at the end of the first half of 2023 was RMB 882,588,767.27[123] Assets and Liabilities - Total assets at the end of the reporting period were 1,081,309,285.61 RMB, a decrease of 2.12% compared to the end of the previous year[13] - Net assets attributable to shareholders of the listed company decreased by 8.03% to 21,492,352.86 RMB compared to the end of the previous year[13] - Monetary funds increased by 44.01% year-on-year, reaching 75.91 million yuan[38] - Accounts receivable increased by 31.46% year-on-year, reaching 25.99 million yuan[38] - Prepayments decreased by 47.80% year-on-year, reaching 12.19 million yuan[38] - Other current assets increased by 35.65% year-on-year, reaching 26.35 million yuan[38] - Construction in progress increased by 33.99% year-on-year, reaching 14.49 million yuan[38] - Other current liabilities decreased by 47.56% to 1,202,779.11, mainly due to a decrease in advance receipts for goods and corresponding deferred output tax[39] - Taxes payable decreased by 46.04% to 894,971.29, primarily due to a reduction in value-added tax payable[39] - Deferred income increased by 99.32% to 17,219,577.41, mainly due to an increase in government subsidies received[39] - Special reserves increased by 56.65% to 1,163,492.12, primarily due to an increase in unused safety production fees[39] - Restricted other monetary funds amounted to 8.7875 million RMB, due to foreign exchange controls in the company's B-share stock USD account[40] - Restricted inventory amounted to 104.56 million RMB, used as collateral for loans[40] - Restricted fixed assets amounted to 270.3769 million RMB, used as collateral for loans[40] - Restricted intangible assets amounted to 55.0831 million RMB, used as collateral and pledge for loans[40] - The company's cumulative undistributed profit (parent company basis) as of June 30, 2024, was -2,073,476,807.58 RMB, leading to a long-term risk of inability to pay cash dividends[45] - The company's debt and financial expenses significantly increased due to a 659 million RMB loan from Wengfu Group in 2019 for the acquisition of Chifeng Ruiyang, resulting in a large debt scale[45] - The company has extended the repayment period of a loan from Wengfu Group to January 31, 2027, with a total principal and interest of 788 million yuan as of December 31, 2023. The annual interest rate is adjusted to 1.2443% from January 1, 2024, to December 31, 2025, and 2.4885% from January 1, 2026, to January 31, 2027[46] - On July 19, 2024, the company borrowed 200 million yuan from its controlling shareholder Xingrong No. 4 and repaid 200 million yuan to Wengfu Group on the same day[46] - The company's monetary funds increased to 75,910,807.00 RMB as of June 30, 2024, up from 52,711,311.07 RMB at the end of 2023[98] - Accounts receivable rose to 25,992,058.61 RMB in June 2024, compared to 19,771,434.97 RMB at the end of 2023[98] - Inventory decreased to 202,354,837.12 RMB in June 2024 from 234,058,114.80 RMB at the end of 2023[98] - Total current assets slightly increased to 405,771,586.34 RMB in June 2024 from 400,270,016.07 RMB at the end of 2023[98] - Fixed assets decreased to 411,019,976.75 RMB in June 2024 from 442,853,798.41 RMB at the end of 2023[98] - Total non-current assets decreased to 675,537,699.27 RMB in June 2024 from 704,430,500.03 RMB at the end of 2023[98] - Total assets decreased to 1,081,309,285.61 RMB in June 2024 from 1,104,700,516.10 RMB at the end of 2023[98] - Short-term borrowings decreased to 177,132,786.09 RMB in June 2024 from 181,693,512.48 RMB at the end of 2023[99] - Total current liabilities decreased to 253,764,765.26 RMB in June 2024 from 1,071,366,537.05 RMB at the end of 2023[99] - Total liabilities decreased to 1,059,816,932.75 RMB in June 2024 from 1,081,332,576.89 RMB at the end of 2023[100] - Total assets increased to 796,700,356.02 RMB as of June 30, 2024, compared to 784,814,097.51 RMB at the end of 2023[102] - Total liabilities rose to 1,033,578,906.63 RMB as of June 30, 2024, up from 1,007,986,405.82 RMB at the end of 2023[103] - Long-term equity investments remained stable at 760,406,400.00 RMB as of June 30, 2024[102] - Total current liabilities decreased to 245,125,872.84 RMB as of June 30, 2024, from 1,006,659,684.57 RMB at the end of 2023[102] - Other receivables slightly increased to 296,044.04 RMB as of June 30, 2024, compared to 295,299.29 RMB at the end of 2023[101] - Cash and cash equivalents increased to RMB 75.91 million at the end of the reporting period, up from RMB 52.71 million at the beginning of the period[194] - Restricted cash due to抵押、质押、冻结等对使用有限制款项 amounted to RMB 8.79 million[194] - Accounts receivable within 1 year increased to RMB 27.36 million from RMB 20.66 million at the beginning of the period[195] - Total accounts receivable increased to RMB 28.62 million from RMB 22.06 million at the beginning of the period[195] - Bad debt provision for accounts receivable increased to RMB 2.63 million from RMB 2.29 million at the beginning of the period[197] - Specific bad debt provision for预计难以收回的款项 remained at RMB 1.26 million with a 100% provision ratio[197] - General credit risk组合的坏账准备 increased to RMB 1.37 million from RMB 1.03 million at the beginning of the period[199] - Bad debt provision for卡帕瑞化学（上海）有限公司 and内蒙古普因药业有限公司 remained at RMB 1.26 million with a 100% provision ratio due to bankruptcy proceedings[199] Production and Technology - The company's pentaerythritol production capacity is 43,000 tons annually, ranking second in the domestic industry[20] - The company has developed a co-production process for mono-, di-, and tri-pentaerythritol, giving it a significant technological advantage[20] - High-end pentaerythritol products have a high technical barrier, with only a few domestic companies mastering the production technology[20] - The company's pentaerythritol production capacity reached 43,000 tons annually, ranking second in the domestic industry, providing significant production scale advantages[27][29] - The company's subsidiary, Chifeng Ruiyang, holds 43 patents, including 11 invention patents and 32 utility model patents, with 17 invention patents pending approval[30] - The company's main products include pentaerythritol series, trimethylolpropane series, edible alcohol, and DDGS feed, with pentaerythritol series products showing a slight price recovery and improved毛利率 compared to the previous year[28] - The company's R&D efforts focus on new product development, technology optimization, and energy-saving improvements, collaborating with top universities and research institutions[26] - The company's pentaerythritol series products are widely used in the production of alkyd resins, synthetic lubricants, and explosives, with high-end products having a competitive edge in the market[24][27] - The company's subsidiary, Chifeng Ruiyang, is recognized as a national high-tech enterprise and a national-level "little giant" specialized and sophisticated enterprise, with multiple R&D platforms[30] Sales and Procurement - The company's sales model for polyol series products is primarily domestic, with a small portion for export, using a prepayment system[25] - The company's production mode adjusts product structure based on market conditions and customer orders, maintaining low inventory for products with small demand or special requirements[25] - The company's procurement mode includes window price and direct purchases for corn, and price comparison for methanol, caustic soda, and n-butyraldehyde[25] Environmental and Compliance - The company's subsidiary Chifeng Ruiyang is listed as a key pollutant discharge unit by the Chifeng Ecological Environment Bureau, covering water, air, soil, and other environmental aspects[51] - Chifeng Ruiyang's wastewater discharge includes chemical oxygen demand (COD) at 87.207 mg/l and ammonia nitrogen at 0.88 mg/l, both within the standard limits[52] - Chifeng Ruiyang's exhaust gas emissions include sulfur dioxide at 36.121 mg/m³, nitrogen oxides at 48.566 mg/m³, and soot at 12.666 mg/m³, all within the standard limits[52] - The company's solid waste includes general solid waste (fly ash, slag, desulfurized gypsum, sludge) and hazardous waste (waste activated carbon, waste mineral oil, waste liquid), all properly disposed of[54] - The company's noise levels comply with the "Emission Standard for Industrial Enterprises Noise at Boundary" (GB1234-2008), with no noise exceeding the standard during the reporting period[54] - The company's wastewater treatment station has been operating well since its commissioning in June 2015[55] - The solid waste incinerator has been temporarily shut down due to external waste treatment measures[55] - The 6MW back-pressure cogeneration project in Chifeng Ruiyang was completed within the validity period of the environmental impact assessment approval[56] - The 20,000t/a trimethylolpropane project and its supporting facilities were completed within the validity period of the environmental impact assessment approval[57] - The company revised its "Emergency Plan for Sudden Environmental Events" in December 2021 and conducted one comprehensive drill and one hazardous waste drill during the reporting period[58] - The company strictly followed the "Environmental Self-M

A 股证券代码：600610 A 股证券简称：中毅达 公告编号：2024-063 B 股证券代码：900906 B 股证券简称：中毅达 B 贵州中毅达股份有限公司 第九届董事会第三次会议决议公告 三、备查文件 1、第九届董事会第三次会议决议； 董事长申苗女士召集和主持了本次会议，公司监事夜文彦、李权、葛娜及高 级管理人员列席了会议。本次会议的召开符合有关法律、法规及《公司章程》的 规定。 二、董事会会议审议情况 （一）审议通过《关于<2024 年半年度报告>及摘要的议案》 详见公司同日披露的《2024 年半年度报告》及摘要。 表决结果：同意票 7 票；反对票 0 票；弃权票 0 票。 本议案在提交董事会前已经公司第九届董事会审计委员会第二次会议审议 通过，并同意提交董事会审议。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 贵州中毅达股份有限公司（以下简称"公司"）第九届董事会第三次会议（以 下简称"本次会议"）于 2024 年 8 月 23 日以现场与通讯表决相结合的方式召开。 会议应参加表决董事 ...

A 股证券代码：600610 A 股证券简称：中毅达 公告编号：2024-064 B 股证券代码：900906 B 股证券简称：中毅达 B 贵州中毅达股份有限公司 贵州中毅达股份有限公司（以下简称"公司"）第九届监事会第三次会议（以 下简称"本次会议"）于 2024 年 8 月 23 日以现场与通讯表决相结合的方式召开。 会议应参加表决监事 3 名，亲自出席监事 3 名。 监事会主席夜文彦先生召集和主持了本次会议。本次会议的召开符合有关法 律、法规及《公司章程》的规定。 二、监事会会议审议情况 （一）审议通过《关于<2024 年半年度报告>及摘要的议案》 第九届监事会第三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 三、备查文件 1、第九届监事会第三次会议决议。 特此公告。 贵州中毅达股份有限公司监事会 经审议，监事会认为：公司《2024 年半年度报告》及摘要的编制、审议符 合相关法律法规及《公司章程》的规定。公司编制的《2024 年半年度报告》及 摘要真实、准确、完整地反映了公司的财 ...

二〇二四年八月 1 股票简称：中毅达 股票代码：600610 股票简称：中毅达 B 股票代码：900906 贵州中毅达股份有限公司 2024 年度向特定对象发行 A 股股票 募集资金使用可行性分析报告 一、本次募集资金的使用计划 本次向特定对象发行股票募集资金总额不超过 21,000.00 万元（含本数），扣 除发行费用后的募集资金净额将用于补充流动资金和偿还借款。 二、本次募集资金投资项目的必要性和可行性分析 （一）本次募集资金投资项目的必要性 1、增强公司资金实力，进一步落实公司发展战略 公司未来计划继续巩固核心产品季戊四醇、三羟甲基丙烷等多元醇系列产品 的竞争优势，优化市场布局与产品品种结构，提高高端产品占比及核心竞争力， 延伸核心产品产业链，努力打造"国内领先、国际一流"的多元醇生产企业。随 着公司发展战略的实施，公司的资金需求不断扩大。 通过本次向特定对象发行股票募集资金，一方面可以有效增强公司资金实力， 缓解公司资金压力；另一方面为公司未来经营水平提升提供有力的资金支持，促 进公司持续健康发展，增强公司综合竞争力。 2、优化资本结构，减轻财务费用压力，提高公司资产质量 报告期各期末，公司资产负债率 ...

| | A | | --- | --- | | 股证券代码：900906 | 股证券代码：600610 | | 股证券简称：中毅达 B | A 股证券简称：中毅达 公告编号：2024-058 | | B B | | 贵州中毅达股份有限公司 关于向特定对象发行股票导致股东权益变动的 提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 一、本次权益变动的基本情况 公司于 2024 年 8 月 13 日召开的第九届董事会第二次会议、第九届监事会第 二次会议审议通过了《关于<贵州中毅达股份有限公司 2024 年度向特定对象发行 A 股股票预案>的议案》《关于公司与特定对象签订附条件生效的股份认购协议 暨关联交易的议案》等涉及本次发行事项的相关议案。 本次发行中，天津信璟全部以现金参与认购。天津信璟为公司控股股东、实 际控制人控制的关联方，本次发行构成关联交易。2024 年 8 月 13 日，天津信璟 与信达证券－兴业银行－信达兴融 4 号集合资产管理计划（以下简称"兴融 4 号"） 签署了《一致行动协议》 ...